Schott Pharma AG & CO KGaA

1SXP

Company Profile

  • Business description

    Schott Pharma AG & CO KGaA is an international provider of drug containment solutions and delivery systems for injectable drugs for pharma, biotech and life-sciences. Its business operates in two segments: Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of revenue is being generated from the DCS segment, which includes products like vials, cartridges, and ampoules, and provides customers with sterile and non-sterile options in standard and high-end formats for drug storage. Geographically, the company generates revenue from Europe, the Middle East, Africa (EMEA), Asia and the South Pacific, North America, and South America.

  • Contact

    Hattenbergstrasse 10
    MainzRP55122
    DEU

    T: +49 6131660

    https://www.schott-pharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    30 September 2026

    Employees

    4,839

Stocks News & Analysis

stocks

ASX REIT downgraded following underwhelming exit

Discounted exit raises investor concerns.
stocks

Ahead of an IPO, the maths behind Databrick’s $190 billion valuation doesn’t add up

The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.
stocks

Takeover proposal agreed for ASX share, other offers permitted

Morningstar analysts’ take on the takeover for this undervalued industrial player.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,919.103.60-0.04%
CAC 408,146.5681.541.01%
DAX 4025,597.48293.421.16%
Dow JONES (US)51,682.6495.40-0.18%
FTSE 10010,767.85108.721.02%
HKSE25,042.71291.931.18%
NASDAQ26,522.54104.250.39%
Nikkei 22565,018.95882.701.38%
NZX 50 Index13,821.2082.060.60%
S&P 5007,650.500.000.00%
S&P/ASX 2008,731.900.700.01%
SSE Composite Index3,949.9138.040.97%

Market Movers